<DOC>
	<DOCNO>NCT00186303</DOCNO>
	<brief_summary>To evaluate role high dose therapy autologous allogeneic hematopoietic cell transplantation treatment chronic lymphocytic leukemia .</brief_summary>
	<brief_title>Transplantation Patients With Chronic Lymphocytic Leukemia</brief_title>
	<detailed_description>To determine effectiveness allogeneic transplantation eradicate chronic lymphocytic leukemia .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<criteria>adequate organ function normal bone marrow cytogenetics active CNS disease For autologous patient 30 % bone marrow involvement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>